Colistimethate and Lung transplant - a phase IV clinical study of FDA data

Summary:

Lung transplant is reported as a side effect among people who take Colistimethate (colistimethate sodium), especially for people who are female, 20-29 old, also take Symdeko, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Lung transplant when taking Colistimethate. It is created by eHealthMe based on reports of 1,500 people who have side effects when taking Colistimethate from the FDA, and is updated regularly.

What is Colistimethate?

Colistimethate has active ingredients of colistimethate sodium. eHealthMe is studying from 1,502 Colistimethate users. Check the latest studies of Colistimethate.

What is Lung transplant?

Lung transplant is found to be associated with 175 drugs and 156 conditions by eHealthMe. Check the latest studies of Lung transplant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

1,500 people reported to have side effects when taking Colistimethate.
Among them, 24 people (1.6%) have Lung transplant.

Could Colistimethate cause Lung transplant?

Among these 24 people:

What is the gender of people who have Lung transplant when taking Colistimethate? *

female: 52.17 %
male: 47.83 %

What is the age of people who have Lung transplant when taking Colistimethate? *

What are other drugs people take besides Colistimethate? *

What are other side effects people have besides Lung transplant? *

Hospitalisation: 3 people, 12.50%
Weight Increased: 1 person, 4.17%
Septic Shock (shock due to blood infection): 1 person, 4.17%
Immunodeficiency Disorders: 1 person, 4.17%
Hypophagia (reduced food intake): 1 person, 4.17%
Exposure To Communicable Disease: 1 person, 4.17%
Cystic Fibrosis (disease of the secretary glands): 1 person, 4.17%
Blindness: 1 person, 4.17%
Bacteraemia (presence of bacteria in the blood): 1 person, 4.17%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 18 people, 75.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 6 people, 25.00%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 5 people, 20.83%
Respiratory Disorder (respiratory disease): 2 people, 8.33%
Pseudomonas Bronchitis (bronchitis by bacterium (genus pseudomonas) of a genus that occurs in soil and detritus): 1 person, 4.17%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 4.17%
Asthma: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Colistimethate and have Lung transplant?

- Check whether Lung transplant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colistimethate:

Colistimethate (1,502 reports)

Lung transplant treatments and more:

Lung transplant (8,509 reports)

Browse all side effects of Colistimethate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung transplant:

Lung transplant (175 drugs)

Browse all the conditions that are associated with Lung transplant:

Lung transplant (156 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on colistimethate sodium (the active ingredients of Colistimethate) and Colistimethate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.